Allogen Biotech Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 2


  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $61.6K

  • Investors
  • 2

Allogen Biotech General Information


Developer of a medical device designed to check, control and manage levels of contaminants and allergens. The company's device offers portable food contamination and allergen-testing services that provide assistance to maintain the purity level in edible items, enabling food manufacturers and food processors to find an alternative to the time-consuming and expensive centralized laboratory testing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Devices and Supplies
Other Commercial Services
Corporate Office
  • 12 Seafield Road, Dublin 3
  • Clontarf
  • Dublin D03 YT25
  • Ireland
+353 (01) 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allogen Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 06-Apr-2018 $61.6K 00000 Completed Generating Revenue
5. Early Stage VC 21-Dec-2015 00000 00000 00000 Completed Generating Revenue
4. Early Stage VC 15-Jan-2014 00000 00000 00000 Completed Generating Revenue
3. Early Stage VC 20-May-2013 000.00 000.00 00000 Completed Generating Revenue
2. Accelerator/Incubator 01-Mar-2012 Completed Startup
1. Angel (individual) 01-Jan-2011 Completed Startup
To view Allogen Biotech’s complete valuation and funding history, request access »

Allogen Biotech Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 5,642 $0.010779 $24.08 $24.08 1x $24.08 16.02%
Ordinary 1,063 $0.010779 $25.35 $25.35 1x $25.35 3.02%
To view Allogen Biotech’s complete cap table history, request access »

Allogen Biotech Executive Team (2)

Name Title Board Seat Contact Info
Benedict Teeling Co-Founder, Chief Executive Officer & Board Member
Derek Graydon Co-Founder & Chief Operating Officer
To view Allogen Biotech’s complete executive team members history, request access »

Allogen Biotech Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allogen Biotech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 SME Instrument Government 000 0000 000000 0
Enterprise Ireland Venture Capital Minority 000 0000 000000 0
To view Allogen Biotech’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »